Climate Change Data

Granules India Limited

Climate Impact & Sustainability Data (2022-23, 2023-24)

Reporting Period: 2022-23

Environmental Metrics

Total Carbon Emissions:109,958 tCO2 eq
Scope 1 Emissions:56,261.97 tCO2eq
Scope 2 Emissions:53,696.04 tCO2eq
Renewable Energy Share:9.03%
Total Energy Consumption:854.54 TJ
Water Consumption:45,396.4 KL
Waste Generated:6,168.41 tons
Carbon Intensity:2.80 Ton/Million Rupees (Scope 1 & 2)

ESG Focus Areas

  • Climate Change
  • Water Management
  • Waste Management
  • Employee Engagement and Well-being
  • Occupational Health & Safety
  • Human Capital Development
  • Business Ethics and Integrity
  • Sustainability Governance
  • Data Privacy and Cyber Security
  • Diversity and Inclusion
  • Community Impact, Relations and Development
  • Innovation, Research and Development (R&D)
  • Responsible Procurement

Environmental Achievements

  • 28.20% Reduction in water intensity
  • 14.03% Reduction in GHG emissions (Scope 1 and Scope 2) intensity
  • ~100% recycling of non-hazardous waste
  • Increased the recycling of hazardous waste by 12.81%
  • Almost threefold increase in renewable energy share to reach 9.03%

Social Achievements

  • 100% Shareholder Grievance Resolved
  • Zero Fatalities
  • 97% Return-to-work rate
  • CSR expenditure of ₹110.02 Mn
  • Pharma Pathshala program trained 1065 trainees
  • Granules WoW (World of Women) mentorship program covered 27 women employees
  • Partnership with TISS for higher education program covered 228 employees

Governance Achievements

  • 96% Average Board Meeting Attendance
  • 50% Independent Directors on the Board
  • Zero data breaches during the reporting period
  • Zero product recalls

Climate Goals & Targets

Long-term Goals:
  • Net Zero by 2050
Medium-term Goals:
  • Scale Green Chemistry product development and set up a flagship green pharma plant with an outlay of ₹2,000 crores
Short-term Goals:
  • Reduce GHG intensity by 5% YoY
  • Reduce energy intensity by 5% YoY
  • Reduce Specific water consumption by 5% YoY
  • Reduce specific waste generation by 5% YoY

Environmental Challenges

  • Price erosion in the US market
  • Distribution challenges with a third-party logistics provider
  • Supply chain disruptions due to geopolitical instability and the COVID-19 pandemic
  • Climate change
  • GHG emissions
  • Water Management
  • Waste Management
  • Data Privacy and Cyber Security
Mitigation Strategies
  • Strategic commercialization efforts in key geographies
  • Improved EBITDA margins and a better cash conversion cycle
  • New greenfield packaging facility in Virginia, USA
  • Partnership with Greenko for green pharmaceutical products
  • Implementation of various energy saving initiatives
  • Increased the percentage of renewable energy
  • Improved operational efficiency
  • Implementation of various water conservation measures
  • Waste optimization measures
  • Preparation/Revision of SOPs like IT Policy, Information Security Backup
  • Upgrading of servers and firewall devices
  • Vulnerability Assessment

Supply Chain Management

Supplier Audits: 90% of value chain partners

Responsible Procurement
  • Supplier Code of Conduct
  • Green Procurement
  • Periodic site audits
  • Regulatory approval checks
  • Regular samples analyses
  • Material risk assessment
  • Compliance to environmental regulations
  • Labor laws
  • Carbon footprint
  • Health and safety parameters

Climate-Related Risks & Opportunities

Transition Risks
  • Global regulatory risks
  • Regulatory risks associated with waste management
Opportunities
  • Comprehensive resource management plans
  • Improving environment preservation
  • Contribution towards climate change mitigation action plans

Reporting Standards

Frameworks Used: GRI, BRSR

Certifications: ISO 14001, ISO 45001

Third-party Assurance: BSI

Sustainable Products & Innovation

  • Green chemistry products
  • Products with near-zero carbon footprint

Awards & Recognition

  • IGBC Green Crusader
  • Silver Winner at the 10th CII National Poka-Yoke Competition
  • Gold Winner at the 10th CII National Poka-Yoke Competition
  • Glory of India Award
  • Best Skill Development Initiative (Pharma)
  • Best Manufacturer Bulk Drug Business Excellence Award

Reporting Period: 2023-24

Environmental Metrics

Total Carbon Emissions:87,886 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:56,254 tCO2e/year
Scope 2 Emissions:31,632 tCO2e/year
Scope 3 Emissions:6,33,837 tCO2e/year
Renewable Energy Share:47%
Total Energy Consumption:875.95 TJ/year
Water Consumption:2,26,082 KL/year
Waste Generated:7236 MT/year
Carbon Intensity:Reduced by 26.7% compared to FY 2022-23

ESG Focus Areas

  • Climate Change
  • Environmental Stewardship
  • Social Responsibility
  • Governance
  • Human Rights
  • Supply Chain Sustainability

Environmental Achievements

  • 22% absolute reduction in Scope 1 and 2 emissions
  • 47% of electricity consumption from renewable sources
  • 88% of hazardous waste sent for co-processing
  • 39% of wastewater recycled

Social Achievements

  • 100% of employees trained on Code of Conduct (including human rights)
  • 31% increase in female employees
  • 100% return-to-work rate
  • Launched a comprehensive mental health program
  • 1200+ students trained through Pharma Pathshala

Governance Achievements

  • Strengthened Board with new Independent Directors
  • ESG-linked performance and incentives for CEO and KMP
  • Enterprise risk management framework established
  • Zero confirmed cases of discrimination

Climate Goals & Targets

Long-term Goals:
  • Net zero emissions by 2050
Medium-term Goals:
  • Achieve net-zero targets by 2050
  • Reduce Scope 1 and 2 absolute emissions by 42% by FY 29-30
  • Reduce Scope 3 absolute emissions by 42% by FY 29-30
  • Work with strategic suppliers to set SBTi emission reduction targets by FY 26-27
  • Achieve zero waste to landfill by FY 30
Short-term Goals:
  • Increase renewable energy mix
  • Develop internal carbon pricing by FY 24-25
  • Energy intensity reduction by 20% by FY 26-27
  • Water intensity reduction by 27% by FY 26-27
  • 27% reduction in waste to landfill by FY 26-27
  • Increase co-processing of waste to 95% by FY 26-27

Environmental Challenges

  • Cyber incident affecting operations and performance
  • Decline in Paracetamol API sales due to higher customer inventory and price erosion
  • Supply chain disruptions due to geopolitical tensions and Red Sea crisis
Mitigation Strategies
  • Enhanced cybersecurity measures
  • Strategic focus on formulation growth
  • Robust risk management system
  • Initiatives to increase renewable energy use
  • Supplier sustainability programs
  • Green molecule platform technologies

Supply Chain Management

Supplier Audits: 100% of key suppliers assessed regularly

Responsible Procurement
  • Supplier Code of Conduct
  • Sustainable sourcing practices
  • Assessment of suppliers on ethical conduct, environmental compliance, labor standards, and health & safety

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
Transition Risks
  • Regulatory changes
  • Market shifts
Opportunities
  • Green molecule platform technologies
  • Renewable energy integration

Reporting Standards

Frameworks Used: GRI, SBTi, TCFD, UNGC

Certifications: ISO 14001, ISO 45001

Third-party Assurance: British Standards Institution (BSI)

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Green molecule platform technologies

Awards & Recognition

  • Economic Times Pharma Award for Excellence in Contribution Towards Sustainability
  • IGBC Green Crusader Award
  • Gold Award for Energy Conservation 2023
  • Economic Times Future Ready Organization Award